Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS

The severe respiratory consequences of the coronavirus disease 2019 (COVID-19) pandemic have prompted the urgent need for novel therapies. Cell-based therapies, primarily using mesenchymal stromal cells (MSCs), have demonstrated safety and potential efficacy in the treatment of critical illness, par...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhiheng, Huang, Yongbo, Zhou, Jianmeng, Deng, Xiumei, He, Weiqun, Liu, Xiaoqing, Li, Yimin, Zhong, Nanshan, Sang, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517471/
https://www.ncbi.nlm.nih.gov/pubmed/34659231
http://dx.doi.org/10.3389/fimmu.2021.738697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517471/
https://www.ncbi.nlm.nih.gov/pubmed/34659231
http://dx.doi.org/10.3389/fimmu.2021.738697

Ejemplares similares